Overview
Segmed, Inc. is a rapidly growing platform focused on providing global access to novel clinical data. Segmed offers millions of diagnostic-grade medical images aimed at accelerating innovation in healthcare, emphasizing de-identified and high-quality medical data. The company upholds privacy and security while facilitating the rapid advancement of AI and clinical applications.
Solutions and Offerings
Segmed serves key sectors within life sciences, healthcare, and technology industries, providing tailored solutions including:
- Life Sciences R&D: Provides regulatory-grade multimodal datasets for longitudinal disease research.
- Medical Devices AI R&D: Offers high-quality databases suitable for AI training and regulatory compliance.
- Clinical Data Management: Services include data de-identification, image data extraction, and exploration of medical imaging data.
- Healthcare Providers: Utilizes medical imaging data to drive innovation.
Key Achievements and Collaborations
- 100 Million Imaging Studies: Segmed's dataset includes over 100 million imaging studies, aiding in AI healthcare solutions development, in collaboration with partners like Bayer.
- Series A Funding: Recently raised $10.4 million in Series A funding, led by investors such as iGan Partners.
- Global Reach: Segmed's data network spans 50 U.S. states and covers data from 5 continents, showcasing extensive influence and resource accessibility.
Leadership Team
- Martin Willemink, Co-founder & CEO: Spearheads strategic vision and growth.
- Jie Wu, Co-founder & CDO: Leverages experience from Facebook to align innovative solutions with client needs.
- Garth Schulz, CFO & COO: Manages financial strategy and operational efficiency.
- Kristin Yakimow, Chief Strategy & Alliance Officer: Focuses on strategic partnerships and alliances.
- Donnie Owen, CTO & CPO: Guides technological innovations and product development.
Financial Milestones and Investors
- Funding: Raised over $20.3 million through multiple rounds.
- Key Investors: Supported by Blumberg Capital and Y Combinator.
Recent Developments
In 2024, Segmed rebranded to Openda, indicating a strategic evolution in its technological solutions and health data industry positioning. Partnerships with companies like Datavant enhance patient insights through advanced data integration.
Corporate Culture and Values
Emphasizes transparency, integrity, and a learning mentality. Committed to social good, focusing on equitable healthcare outcomes, fostering a culture of innovation and attracting dedicated talent.
Competitive Landscape
Segmed operates in a competitive market with notable players in medical imaging and health data analytics, including:
- InterSystems, Mach7, eClinicalWorks
- MediLumine, Image Analysis Group, Akoya Biosciences, QUIBIM
- Gradient Health, Gesund.ai, ScImage, Pie Medical Imaging, DoseSpot
Market Position and Performance
Estimated at $5 million in annual revenue with a workforce of 47 employees. Utilizes advanced technology like Google Analytics and HubSpot for agile analytics and customer engagement.
Technological Edge
Leverages a robust tech stack, offering insights into user behavior and market trends for informed strategic planning.
Notable Competitors Analysis
- MediLumine: Creating imaging products advantageous for clinical trials, with a strong international presence.
- Image Analysis Group: AI-powered drug development and precision medicine.
- Akoya Biosciences: Spatial phenotyping solutions from discovery to clinical research.
- QUIBIM: AI in medical imaging focusing on precision medicine.
Actionable Insight
Understanding the competitive landscape provides opportunities for strategic partnerships and investments, particularly with artificial intelligence developers or iCROs. Collaborations could enhance technological capabilities and market reach in the healthcare technology sector.
